Exosens lifts nine-month revenue to €386.9M as Q3 growth speeds up to 23.5%
Exosens reported nine-month 2026 revenue of €386.9M and said it is on track for its upgraded guidance, according to a GlobeNewswire release.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
French optronics maker Exosens reported 9M 2026 revenue of €386.9M, up 18.0% year on year. According to the press release distributed by GlobeNewswire, third-quarter growth accelerated to 23.5% from a year earlier.
Adjusted gross margin came in at €194.9M, or 50.4%, down 85 basis points year on year, which the company linked to product mix and U.S. staffing costs. Exosens said it remains on track to meet its upgraded 2026 guidance and reaffirmed expected growth of about 20% in revenue and about 25% in adjusted EBITDA versus 2025.
The company also secured the first low-rate initial production order for its BiNOD device from the U.S. Army.
why it matters
For markets, the key points are the faster growth and the reaffirmed outlook, which suggest steady demand and expanding capacity in Europe. The lower gross margin shows growth is coming with thinner profitability, so investors will watch how volume and margins balance. The U.S. Army order adds some revenue visibility over the medium term.
market impact
Европейский оборонный и фотонический сектор: рост спроса и подтвержденный прогноз поддерживают интерес к бумагам Exosens
tags
instruments
sources
- Exosens (EXENS) Q3 Revenue Up 23.5%; 9M Sales €386.9M — globenewswire.com, 27 October 2026 at 06:15 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗